Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Profit After Tax: 2009-2020

Historic Profit After Tax for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $407.3 million.

  • Neurocrine Biosciences' Profit After Tax rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $444.8 million, marking a year-over-year increase of 376.23%. This contributed to the annual value of $407.3 million for FY2020, which is 1000.81% up from last year.
  • Neurocrine Biosciences' Profit After Tax amounted to $407.3 million in FY2020, which was up 1,000.81% from $37.0 million recorded in FY2019.
  • In the past 5 years, Neurocrine Biosciences' Profit After Tax registered a high of $407.3 million during FY2020, and its lowest value of -$142.5 million during FY2017.
  • For the 3-year period, Neurocrine Biosciences' Profit After Tax averaged around $155.1 million, with its median value being $37.0 million (2019).
  • As far as peak fluctuations go, Neurocrine Biosciences' Profit After Tax crashed by 58.65% in 2016, and later surged by 1,000.81% in 2020.
  • Over the past 5 years, Neurocrine Biosciences' Profit After Tax (Yearly) stood at -$141.1 million in 2016, then dropped by 1.03% to -$142.5 million in 2017, then skyrocketed by 114.80% to $21.1 million in 2018, then spiked by 75.36% to $37.0 million in 2019, then surged by 1,000.81% to $407.3 million in 2020.